Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista da Associação Médica Brasileira (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021001001233 |
Resumo: | SUMMARY OBJECTIVE: To evaluate the association between muscle mass depletion and compromising of the cell membrane integrity and clinical–anthropometric characteristics in patients with nonalcoholic fatty liver disease. METHODS: This observational study evaluated waist circumference, body mass index, and waist-to-height ratio in patients with nonalcoholic fatty liver disease. Skeletal mass index corrected by weight and impairment of cell membrane integrity were assessed using bioelectrical impedance analysis. RESULTS: In 56 patients, muscle mass depletion was observed in 62.5% and cell membrane impairment in 28.6%. The metabolic syndrome and elevated aspartate aminotransferase were the only clinical factors associated with mass depletion (p<0.05). The linear regression analysis showed association between skeletal mass index and waist-to-height ratio and waist circumference, after adjustments (p<0.05). The phase angle value was not different between those with and without mass depletion, and also it did not have correlation with skeletal mass index and clinical parameters (p>0.05). CONCLUSIONS: The prevalence of mass depletion and cell membrane impairment was higher in patients with nonalcoholic fatty liver disease. The muscle mass depletion was associated with central obesity, aspartate aminotransferase elevated, and metabolic syndrome; however, the phase angle is not associated with clinical and anthropometric data. |
id |
AMB-1_3985a6d69c3e9d66612e883e45ee0966 |
---|---|
oai_identifier_str |
oai:scielo:S0104-42302021001001233 |
network_acronym_str |
AMB-1 |
network_name_str |
Revista da Associação Médica Brasileira (Online) |
repository_id_str |
|
spelling |
Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver diseaseNon-alcoholic fatty liver diseaseSkeletal muscleBioelectrical impedanceObesityCentral obesitySUMMARY OBJECTIVE: To evaluate the association between muscle mass depletion and compromising of the cell membrane integrity and clinical–anthropometric characteristics in patients with nonalcoholic fatty liver disease. METHODS: This observational study evaluated waist circumference, body mass index, and waist-to-height ratio in patients with nonalcoholic fatty liver disease. Skeletal mass index corrected by weight and impairment of cell membrane integrity were assessed using bioelectrical impedance analysis. RESULTS: In 56 patients, muscle mass depletion was observed in 62.5% and cell membrane impairment in 28.6%. The metabolic syndrome and elevated aspartate aminotransferase were the only clinical factors associated with mass depletion (p<0.05). The linear regression analysis showed association between skeletal mass index and waist-to-height ratio and waist circumference, after adjustments (p<0.05). The phase angle value was not different between those with and without mass depletion, and also it did not have correlation with skeletal mass index and clinical parameters (p>0.05). CONCLUSIONS: The prevalence of mass depletion and cell membrane impairment was higher in patients with nonalcoholic fatty liver disease. The muscle mass depletion was associated with central obesity, aspartate aminotransferase elevated, and metabolic syndrome; however, the phase angle is not associated with clinical and anthropometric data.Associação Médica Brasileira2021-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021001001233Revista da Associação Médica Brasileira v.67 n.9 2021reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/1806-9282.20201016info:eu-repo/semantics/openAccessBarreto,Iasmin dos SantosSantos,Raquel Oliveira dosRocha,RaquelSouza,Claudineia deAlmeida,NaiadeVieira,Luiza ValoisLeiróz,RafaelSarno,ManoelDaltro,CarlaCotrim,Helma Pinchemeleng2021-11-17T00:00:00Zoai:scielo:S0104-42302021001001233Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2021-11-17T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false |
dc.title.none.fl_str_mv |
Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease |
title |
Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease |
spellingShingle |
Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease Barreto,Iasmin dos Santos Non-alcoholic fatty liver disease Skeletal muscle Bioelectrical impedance Obesity Central obesity |
title_short |
Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease |
title_full |
Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease |
title_fullStr |
Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease |
title_full_unstemmed |
Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease |
title_sort |
Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease |
author |
Barreto,Iasmin dos Santos |
author_facet |
Barreto,Iasmin dos Santos Santos,Raquel Oliveira dos Rocha,Raquel Souza,Claudineia de Almeida,Naiade Vieira,Luiza Valois Leiróz,Rafael Sarno,Manoel Daltro,Carla Cotrim,Helma Pinchemel |
author_role |
author |
author2 |
Santos,Raquel Oliveira dos Rocha,Raquel Souza,Claudineia de Almeida,Naiade Vieira,Luiza Valois Leiróz,Rafael Sarno,Manoel Daltro,Carla Cotrim,Helma Pinchemel |
author2_role |
author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Barreto,Iasmin dos Santos Santos,Raquel Oliveira dos Rocha,Raquel Souza,Claudineia de Almeida,Naiade Vieira,Luiza Valois Leiróz,Rafael Sarno,Manoel Daltro,Carla Cotrim,Helma Pinchemel |
dc.subject.por.fl_str_mv |
Non-alcoholic fatty liver disease Skeletal muscle Bioelectrical impedance Obesity Central obesity |
topic |
Non-alcoholic fatty liver disease Skeletal muscle Bioelectrical impedance Obesity Central obesity |
description |
SUMMARY OBJECTIVE: To evaluate the association between muscle mass depletion and compromising of the cell membrane integrity and clinical–anthropometric characteristics in patients with nonalcoholic fatty liver disease. METHODS: This observational study evaluated waist circumference, body mass index, and waist-to-height ratio in patients with nonalcoholic fatty liver disease. Skeletal mass index corrected by weight and impairment of cell membrane integrity were assessed using bioelectrical impedance analysis. RESULTS: In 56 patients, muscle mass depletion was observed in 62.5% and cell membrane impairment in 28.6%. The metabolic syndrome and elevated aspartate aminotransferase were the only clinical factors associated with mass depletion (p<0.05). The linear regression analysis showed association between skeletal mass index and waist-to-height ratio and waist circumference, after adjustments (p<0.05). The phase angle value was not different between those with and without mass depletion, and also it did not have correlation with skeletal mass index and clinical parameters (p>0.05). CONCLUSIONS: The prevalence of mass depletion and cell membrane impairment was higher in patients with nonalcoholic fatty liver disease. The muscle mass depletion was associated with central obesity, aspartate aminotransferase elevated, and metabolic syndrome; however, the phase angle is not associated with clinical and anthropometric data. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-09-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021001001233 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021001001233 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/1806-9282.20201016 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Médica Brasileira |
publisher.none.fl_str_mv |
Associação Médica Brasileira |
dc.source.none.fl_str_mv |
Revista da Associação Médica Brasileira v.67 n.9 2021 reponame:Revista da Associação Médica Brasileira (Online) instname:Associação Médica Brasileira (AMB) instacron:AMB |
instname_str |
Associação Médica Brasileira (AMB) |
instacron_str |
AMB |
institution |
AMB |
reponame_str |
Revista da Associação Médica Brasileira (Online) |
collection |
Revista da Associação Médica Brasileira (Online) |
repository.name.fl_str_mv |
Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB) |
repository.mail.fl_str_mv |
||ramb@amb.org.br |
_version_ |
1754212836540678144 |